Literature DB >> 3343806

[IgM antibodies to toxic shock syndrome toxin-1 in human sera and human immunoglobulins].

N Dickgiesser1, F Düzgün.   

Abstract

IgM antibodies against toxic shock syndrome toxin-1 (TSST-1) in 1990 human sera and in 14 human immunoglobulin preparations were determined using an enzyme linked immunosorbent assay. High levels of IgM antibody titres could be found beginning with the third month of life within the first 5 years of age. They were also very common in the age group of 21 up to 25 years. In no case of IgM antibodies with titres higher than 1:251 symptoms could be observed as described for toxic shock syndrome. Of the human immunoglobulin preparations, Pentaglobin contained IgM antibodies against TSST-1 only. The results show that most of the infections with TSST-1 producing Staphylococcus aureus are of subclinical nature or are of less dramatic course than the commonly known toxic shock syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3343806     DOI: 10.1007/bf01735206

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  11 in total

1.  [IgG antibodies against toxic shock syndrome toxin 1 in human immunoglobulins].

Authors:  N Dickgiesser; B Kustermann
Journal:  Klin Wochenschr       Date:  1986-07-15

2.  [IgG antibodies to toxic shock syndrome toxin-1 (TSST-1) in human sera].

Authors:  N Dickgiesser; B Kustermann
Journal:  Klin Wochenschr       Date:  1987-03-16

3.  Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin.

Authors:  S J Stolz; J P Davis; J M Vergeront; B A Crass; P J Chesney; P J Wand; M S Bergdoll
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

4.  Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model.

Authors:  J C de Azavedo; T J Foster; P J Hartigan; J P Arbuthnott; M O'Reilly; B N Kreiswirth; R P Novick
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls.

Authors:  B Christensson; S A Hedström
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1985-04

6.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

7.  Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

Authors:  J M Vergeront; S J Stolz; B A Crass; D B Nelson; J P Davis; M S Bergdoll
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

8.  Silver staining of proteins in polyacrylamide gels: increased sensitivity by a blue toning.

Authors:  G Berson
Journal:  Anal Biochem       Date:  1983-10-01       Impact factor: 3.365

9.  Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.

Authors:  N J Poindexter; P M Schlievert
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

10.  Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers.

Authors:  P F Bonventre; C Linnemann; L S Weckbach; J L Staneck; C R Buncher; E Vigdorth; H Ritz; D Archer; B Smith
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.